What is Sabra Health Care Reit Inc's earnings per share (EPS)?

Sabra Health Care Reit Inc (SBRA) reported diluted earnings per share of $0.64 for fiscal year 2025. This represents a 18.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Sabra Health Care Reit Inc Financials

SBRA

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Sabra Health Care Reit Inc (SBRA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SBRA FY2025 2026-04-29

Cash generation stayed durable over 3 years as reported earnings normalized, revealing a leveraged asset base getting more productive.

From FY2023 to FY2025, net income climbed to $155.6M while operating cash flow stayed near $300M in each year; that means cash generation was steadier than GAAP earnings implied, and the profit recovery was partly an accounting catch-up to a business that was already producing cash. Because dividends absorbed 83.0% of FY2025 operating cash flow, most of that recurring cash is still committed before debt reduction can materially accelerate.

The balance sheet is long-term-debt funded rather than cash-rich: FY2025 cash was only $71.5M against $2.53B of long-term debt, so financial flexibility relies more on dependable operating inflows and market access than on a large cash reserve.

This was not just growth by asset accumulation. Revenue rose while total assets stayed around $5.4B across FY2023-FY2025. That lifted return on assets from 0.3% to 2.8%, showing the portfolio produced more income from roughly the same capital base instead of simply becoming larger.

Financial Health Signals

Financial Profile 26/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Sabra Health Care Reit Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Sabra Health Care Reit Inc's revenue grew 10.2% year-over-year to $774.6M, a solid pace of expansion. This earns a growth score of 49/100.

Leverage

Sabra Health Care Reit Inc carries a low D/E ratio of 0.90, meaning only $0.90 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 84/100, indicating a strong balance sheet with room for future borrowing.

Returns

Sabra Health Care Reit Inc generates a 5.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 21/100. This is up from 4.6% the prior year.

Piotroski F-Score Neutral

5/9

Sabra Health Care Reit Inc passes 5 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.24x

For every $1 of reported earnings, Sabra Health Care Reit Inc generates $2.24 in operating cash flow ($348.6M OCF vs $155.6M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$774.6M

YoY+10.2%

5Y CAGR+5.3%

10Y CAGR+12.5%

Sabra Health Care Reit Inc generated $774.6M in revenue in fiscal year 2025. This represents an increase of 10.2% from the prior year.

EBITDA

N/A

Net Income

$155.6M

YoY+22.8%

5Y CAGR+2.4%

10Y CAGR+7.0%

Sabra Health Care Reit Inc reported $155.6M in net income in fiscal year 2025. This represents an increase of 22.8% from the prior year.

EPS (Diluted)

$0.64

YoY+18.5%

5Y CAGR-0.9%

10Y CAGR-5.4%

Sabra Health Care Reit Inc earned $0.64 per diluted share (EPS) in fiscal year 2025. This represents an increase of 18.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$71.5M

YoY+18.3%

5Y CAGR+3.9%

10Y CAGR+25.4%

Sabra Health Care Reit Inc held $71.5M in cash against $2.5B in long-term debt as of fiscal year 2025.

Dividends Per Share

$1.20

YoY+0.0%

5Y CAGR-2.3%

10Y CAGR-2.8%

Sabra Health Care Reit Inc paid $1.20 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding

252M

YoY+6.0%

5Y CAGR+3.7%

10Y CAGR+14.5%

Sabra Health Care Reit Inc had 252M shares outstanding in fiscal year 2025. This represents an increase of 6.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

20.1%

YoY+2.1pp

5Y CAGR-3.0pp

10Y CAGR-13.2pp

Sabra Health Care Reit Inc's net profit margin was 20.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.1 percentage points from the prior year.

Return on Equity

5.5%

YoY+0.9pp

5Y CAGR+1.5pp

10Y CAGR-2.0pp

Sabra Health Care Reit Inc's ROE was 5.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.9 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

SBRA Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$774.6M+10.2%	$703.2M+8.6%	$647.5M+3.6%	$624.8M+9.7%	$569.5M-4.8%	$598.6M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$53.7M+7.3%	$50.1M+5.5%	$47.5M+20.0%	$39.6M+14.1%	$34.7M+5.8%	$32.8M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$112.5M-2.4%	$115.3M+2.0%	$113.0M+7.1%	$105.5M+6.9%	$98.6M-1.8%	$100.4M
Income Tax	$1.8M+82.8%	$1.0M-49.8%	$2.0M+61.2%	$1.2M-32.7%	$1.8M+159.9%	$710K
Net Income	$155.6M+22.8%	$126.7M+821.1%	$13.8M+117.7%	-$77.6M+31.5%	-$113.3M-181.8%	$138.4M
EPS (Diluted)	$0.64+18.5%	$0.54+800.0%	$0.06+117.6%	$-0.34+34.6%	$-0.52-177.6%	$0.67

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$221.8M+4.6%	$211.9M+11.5%	$190.0M+0.5%	$189.2M+3.1%	$183.5M+0.7%	$182.3M+2.4%	$178.0M+1.1%	$176.1M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$14.9M-6.6%	$15.9M+26.7%	$12.6M+0.4%	$12.5M-1.7%	$12.7M-2.3%	$13.0M+5.1%	$12.4M-2.6%	$12.7M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$28.4M-1.8%	$28.9M+0.1%	$28.9M+4.9%	$27.5M+1.7%	$27.1M-3.5%	$28.1M-4.7%	$29.5M+0.5%	$29.3M
Income Tax	$526K+7.1%	$491K+12.6%	$436K-12.3%	$497K+20.3%	$413K+8.7%	$380K+243.4%	-$265K-160.6%	$437K
Net Income	$40.9M+50.2%	$27.2M+20.8%	$22.5M-65.6%	$65.5M+62.6%	$40.3M-13.7%	$46.7M+56.8%	$29.8M+24.2%	$24.0M
EPS (Diluted)	$0.16	N/A	$0.09-66.7%	$0.27+58.8%	$0.17	N/A	$0.13+30.0%	$0.10

SBRA Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$5.5B+3.6%	$5.3B-1.5%	$5.4B-6.3%	$5.7B-3.7%	$6.0B-0.3%	$6.0B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$71.5M+18.3%	$60.5M+46.5%	$41.3M-16.3%	$49.3M-56.0%	$112.0M+89.6%	$59.1M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.7B+4.2%	$2.6B-0.8%	$2.6B-4.0%	$2.7B+4.0%	$2.6B+0.4%	$2.6B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$2.5B+4.6%	$2.4B+0.1%	$2.4B-3.7%	$2.5B+4.7%	$2.4B+0.9%	$2.4B
Total Equity	$2.8B+2.9%	$2.7B-2.2%	$2.8B-8.3%	$3.1B-9.6%	$3.4B-0.9%	$3.4B
Retained Earnings	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$5.6B+1.8%	$5.5B-1.3%	$5.6B+4.4%	$5.3B+1.8%	$5.2B-1.3%	$5.3B-1.2%	$5.4B+0.3%	$5.4B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$116.5M+62.9%	$71.5M-64.3%	$200.6M+110.8%	$95.2M+320.1%	$22.7M-62.5%	$60.5M-4.0%	$63.0M+73.1%	$36.4M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.8B+5.0%	$2.7B-2.5%	$2.7B+4.6%	$2.6B+3.4%	$2.5B-1.2%	$2.6B-2.2%	$2.6B+1.2%	$2.6B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$2.7B+5.4%	$2.5B-2.4%	$2.6B+4.5%	$2.5B+3.6%	$2.4B-1.0%	$2.4B-2.1%	$2.5B+1.0%	$2.4B
Total Equity	$2.8B-1.3%	$2.8B-0.1%	$2.8B+4.2%	$2.7B+0.3%	$2.7B-1.4%	$2.7B-0.1%	$2.7B-0.6%	$2.8B
Retained Earnings	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SBRA Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$348.6M+12.3%	$310.5M+3.3%	$300.6M-4.8%	$315.7M-11.4%	$356.4M+0.4%	$354.9M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$378.0M-246.7%	-$109.0M-205.7%	$103.1M+147.7%	-$216.2M+35.7%	-$336.2M-146.4%	-$136.5M
Financing Cash Flow	$40.8M+122.4%	-$181.6M+55.7%	-$410.3M-153.7%	-$161.7M-636.5%	$30.1M+114.9%	-$202.1M
Dividends Paid	$289.5M+3.3%	$280.1M+1.0%	$277.4M+0.1%	$277.2M+5.4%	$262.9M-5.5%	$278.3M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$98.4M+12.5%	$87.4M-12.5%	$100.0M+23.5%	$81.0M+0.9%	$80.3M+0.4%	$80.0M-18.1%	$97.7M+21.9%	$80.1M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$105.1M+9.8%	-$116.5M+41.7%	-$199.8M-342.8%	-$45.1M-174.5%	-$16.4M-188.6%	$18.6M+132.5%	-$57.0M+0.5%	-$57.3M
Financing Cash Flow	$52.1M+151.6%	-$100.9M-148.9%	$206.2M+461.4%	$36.7M+136.3%	-$101.2M-0.3%	-$101.0M-623.5%	-$14.0M+69.9%	-$46.4M
Dividends Paid	$75.7M+1.1%	$74.8M+4.0%	$71.9M+0.8%	$71.4M0.0%	$71.4M+0.6%	$71.0M+1.0%	$70.3M+1.2%	$69.5M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SBRA Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	20.1%+2.1pp	18.0%+15.9pp	2.1%+14.5pp	-12.4%+7.5pp	-19.9%-43.0pp	23.1%
Return on Equity	5.5%+0.9pp	4.6%+4.1pp	0.5%+3.0pp	-2.5%+0.8pp	-3.4%-7.4pp	4.1%
Return on Assets	2.8%+0.4pp	2.4%+2.1pp	0.3%+1.6pp	-1.4%+0.5pp	-1.9%-4.2pp	2.3%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.90+0.0	0.88+0.0	0.86+0.0	0.82+0.1	0.71+0.0	0.70
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	18.4%+5.6pp	12.8%+1.0pp	11.9%-22.8pp	34.6%+12.7pp	22.0%-3.7pp	25.6%+8.9pp	16.7%+3.1pp	13.6%
Return on Equity	1.5%+0.5pp	1.0%+0.2pp	0.8%-1.6pp	2.4%+0.9pp	1.5%-0.2pp	1.7%+0.6pp	1.1%+0.2pp	0.9%
Return on Assets	0.7%+0.2pp	0.5%+0.1pp	0.4%-0.8pp	1.2%+0.5pp	0.8%-0.1pp	0.9%+0.3pp	0.6%+0.1pp	0.4%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.96+0.1	0.90-0.0	0.920.0	0.91+0.0	0.890.0	0.88-0.0	0.90+0.0	0.89
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Healthcare Tr Amer Inc HR

$6.7B

National Health Investors NHI

$3.7B

Caretrust CTRE

$8.7B

AMERICAN HEALTHCARE REIT INC AHR

$9.6B

Medical Prop MPW

$3.0B

Frequently Asked Questions

What is Sabra Health Care Reit Inc's annual revenue?

Sabra Health Care Reit Inc (SBRA) reported $774.6M in total revenue for fiscal year 2025. This represents a 10.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Sabra Health Care Reit Inc's revenue growing?

Sabra Health Care Reit Inc (SBRA) revenue grew by 10.2% year-over-year, from $703.2M to $774.6M in fiscal year 2025.

Is Sabra Health Care Reit Inc profitable?

Yes, Sabra Health Care Reit Inc (SBRA) reported a net income of $155.6M in fiscal year 2025, with a net profit margin of 20.1%.

How much debt does Sabra Health Care Reit Inc have?

As of fiscal year 2025, Sabra Health Care Reit Inc (SBRA) had $71.5M in cash and equivalents against $2.5B in long-term debt.

What is Sabra Health Care Reit Inc's net profit margin?

Sabra Health Care Reit Inc (SBRA) had a net profit margin of 20.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Sabra Health Care Reit Inc pay dividends?

Yes, Sabra Health Care Reit Inc (SBRA) paid $1.20 per share in dividends during fiscal year 2025.

What is Sabra Health Care Reit Inc's return on equity (ROE)?

Sabra Health Care Reit Inc (SBRA) has a return on equity of 5.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Sabra Health Care Reit Inc's operating cash flow?

Sabra Health Care Reit Inc (SBRA) generated $348.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Sabra Health Care Reit Inc's total assets?

Sabra Health Care Reit Inc (SBRA) had $5.5B in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Sabra Health Care Reit Inc have outstanding?

Sabra Health Care Reit Inc (SBRA) had 252M shares outstanding as of fiscal year 2025.

What is Sabra Health Care Reit Inc's debt-to-equity ratio?

Sabra Health Care Reit Inc (SBRA) had a debt-to-equity ratio of 0.90 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Sabra Health Care Reit Inc's return on assets (ROA)?

Sabra Health Care Reit Inc (SBRA) had a return on assets of 2.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Sabra Health Care Reit Inc's Piotroski F-Score?

Sabra Health Care Reit Inc (SBRA) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Sabra Health Care Reit Inc's earnings high quality?

Sabra Health Care Reit Inc (SBRA) has an earnings quality ratio of 2.24x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Sabra Health Care Reit Inc?

Sabra Health Care Reit Inc (SBRA) scores 26 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.